P064 Risk-reducing mastectomy in ovarian cancer patients with BRCA1/2 pathogenic variants: a comprehensive review
Main Authors: | E.-A. Bonci, R. O’Connell, T. McVeigh, Z. Kemp, A. George, M.-J. Cardoso, S. Banerjee, G. Gui, M.-K. Tasoulis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623001832 |
Similar Items
-
BRCA 1/BRCA 2 Pathogenic/Likely Pathogenic Variant Patients with Breast, Ovarian, and Other Cancers
by: Osman K., et al.
Published: (2022-12-01) -
Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in BRCA1/2: Overall Survival, Racial, and Ethnic Differences
by: Sukh Makhnoon, et al.
Published: (2022-01-01) -
Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01) -
Case Review: Whole-Exome Sequencing Analyses Identify Carriers of a Known Likely Pathogenic Intronic <i>BRCA1</i> Variant in Ovarian Cancer Cases Clinically Negative for Pathogenic <i>BRCA1</i> and <i>BRCA2</i> Variants
by: Wejdan M. Alenezi, et al.
Published: (2022-04-01) -
Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024-03-01)